We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.07B
1-Year Est. Return 78.71%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+78.71%
3 Year Est. Return
+323.31%
5 Year Est. Return
+574.14%
10 Year Est. Return
+3,824.29%
AUM
$2.8B
AUM Growth
+$635M
Cap. Flow
+$218M
Cap. Flow %
7.79%
Top 10 Hldgs %
49.77%
Holding
313
New
122
Increased
18
Reduced
66
Closed
70

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$183M
2
ESGR
Enstar Group
ESGR
+$157M
3
BPMC
Blueprint Medicines
BPMC
+$138M
4
SKX
Skechers
SKX
+$137M
5
DNB
Dun & Bradstreet
DNB
+$129M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$208M
2
PDCO
Patterson Companies, Inc.
PDCO
+$149M
3
ATSG
Air Transport Services Group
ATSG
+$95M
4
PLYA
Playa Hotels & Resorts
PLYA
+$93.6M
5
SWI
SolarWinds Corporation Common Stock
SWI
+$90.9M

Sector Composition

Rank Sector Weight
1 Financials 32.71%
2 Miscellaneous 18.12%
3 Healthcare 14.93%
4 Consumer Discretionary 10.35%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NHICW
201
NewHold Investment Corp III Warrants
NHICW
$24K ﹤0.01%
+74,997
New +$20.2K
RAC.WS
202
Rithm Acquisition Corp Warrants
RAC.WS
$24K ﹤0.01%
+50,000
New +$21K
FSHPR
203
Flag Ship Acquisition Corp Right
FSHPR
$23K ﹤0.01%
173,567
– –
GSHRW
204
Gesher Acquisition Corp II Warrants
GSHRW
$1.94M
$23K ﹤0.01%
+97,945
New +$27.8K
SVCCW
205
Stellar V Capital Corp Warrant
SVCCW
$22K ﹤0.01%
+97,931
New +$22.3K
GCTS.WS
206
GCT Semiconductor Holding Warrants
GCTS.WS
$13.5M
$20K ﹤0.01%
209,417
– –
RTACW
207
Renatus Tactical Acquisition Corp I Warrant
RTACW
$8.15M
$20K ﹤0.01%
+9,998
New +$20.2K
FVNNR
208
Future Vision II Acquisition Corp Right
FVNNR
$19K ﹤0.01%
99,339
– –
RAAQU
209
DELISTED
Real Asset Acquisition Corp Unit
RAAQU
$17K ﹤0.01%
+1,617
New +$16.5K
TAVIR
210
Tavia Acquisition Corp Right
TAVIR
$16K ﹤0.01%
97,949
-151,851
-61% -$23.6K
PGACR
211
Pantages Capital Acquisition Corp Right
PGACR
$16K ﹤0.01%
101,340
– –
DYCQR
212
DELISTED
DT Cloud Acquisition Corp Right
DYCQR
$15K ﹤0.01%
86,985
– –
HIMS icon
213
PUT
Hims & Hers Health
HIMS
$6.51B
$14K ﹤0.01%
+500
New +$22.6K
TDACW
214
Translational Development Acquisition Corp Warrants
TDACW
$16M
$12K ﹤0.01%
50,000
– –
TONT.U
215
Graf Global Corp Units
TONT.U
$10K ﹤0.01%
+997
New +$10.4K
DTSQU
216
DT Cloud Star Acquisition Corp Units
DTSQU
$10K ﹤0.01%
991
– –
AFJKR
217
Aimei Health Technology Co Right
AFJKR
$9K ﹤0.01%
38,931
– –
IPCXR
218
DELISTED
Inflection Point Acquisition Corp III Rights
IPCXR
$9K ﹤0.01%
+25,000
New +$8.88K
FYBR
219
PUT
DELISTED
Frontier Communications
FYBR
$8K ﹤0.01%
161
– –
EURKR
220
Eureka Acquisition Corp Right
EURKR
$8K ﹤0.01%
34,723
-5
-0% -$1
FVNNU
221
Future Vision II Acquisition Corp Units
FVNNU
$7K ﹤0.01%
+672
New +$7.21K
TACHW
222
Titan Acquisition Corp Warrants
TACHW
$7.59M
$7K ﹤0.01%
+20,058
New +$5.77K
TGI
223
PUT
DELISTED
Triumph Group
TGI
$6K ﹤0.01%
+57
New +$1.45K
LPBBU
224
Launch Two Acquisition Corp Unit
LPBBU
$4K ﹤0.01%
385
– –
CHEB.WS
225
DELISTED
Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHEB.WS
$3K ﹤0.01%
34,236
-55,588
-62% -$4.31K
7 8
9
10 11

Similar funds

PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Glazer Capital LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Glazer Capital LLC held 313 positions worth $2.8B, up 29% from $2.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Glazer Capital LLC deployed $218M of net new capital in Q2 2025, opening 122 new positions and adding to 18 existing holdings. Its largest new stake was SpringWorks Therapeutics: 4,107,199 shares worth $193M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $78.8M trimmed.

  • Glazer Capital LLC's largest Q2 2025 buy was SpringWorks Therapeutics: 4,107,199 shares worth $193M.
  • Glazer Capital LLC added most to Enstar Group in Q2 2025, an estimated $157M increase.
  • Glazer Capital LLC's biggest Q2 2025 reduction was Kellanova, cutting an estimated $78.8M.
  • Glazer Capital LLC fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $208M.
  • Glazer Capital LLC's ten largest holdings make up 50% of its $2.8B portfolio in Q2 2025.
  • Glazer Capital LLC opened 122 new positions and closed 70 in Q2 2025.
  • Glazer Capital LLC's portfolio value rose 29% quarter-over-quarter to $2.8B.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.